12:00 AM
Mar 19, 2012
 |  BC Week In Review  |  Company News  |  Deals

Beijing Zhongshan Golden Bridge Biotechnology, OriGene deal

OriGene acquired oncology diagnostic reagent company ZsBio for an undisclosed sum. OriGene, which provides gene-based...

Read the full 52 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >